KALA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
KALA BIO Inc is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows weak financial performance, bearish technical indicators, insider selling activity, and lacks positive catalysts or strong analyst support. It is better to avoid this stock at the moment.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 38.6, offering no clear signal. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below its pivot level of 0.395, indicating a bearish trend. Support levels are at 0.361 and 0.34, while resistance levels are at 0.429 and 0.45.
NULL identified. No recent news or significant positive developments.
Insiders are selling, with a 177.30% increase in selling activity over the last month. Financial performance shows declining net income (-15.49% YoY) and EPS (-44.56% YoY). No recent congress trading data or influential figure activity.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped to -$7,564,000 (-15.49% YoY), and EPS fell to -1.07 (-44.56% YoY). Gross margin remained at 0 with no improvement.
No specific analyst coverage or ratings for KALA BIO Inc. The provided analyst data is for Cullinan Therapeutics, which is unrelated to KALA.
